196 related articles for article (PubMed ID: 33210244)
1. Age-dependent anticonvulsant actions of perampanel and brivaracetam in the methyl-6,7-dimethoxy-4-ethyl-beta-carboline-3-carboxylate (DMCM) model of seizures in developing rats.
Culjat M; Huizenga MN; Forcelli PA
Pharmacol Rep; 2021 Feb; 73(1):296-302. PubMed ID: 33210244
[TBL] [Abstract][Full Text] [Related]
2. Ontogenic profile of seizures evoked by the beta-carboline DMCM (methyl-6,7-dimethoxy-4-ethyl-β-carboline-3-carboxylate) in rats.
Kulick C; Gutherz S; Kondratyev A; Forcelli PA
Eur J Pharmacol; 2014 Oct; 740():662-8. PubMed ID: 24967532
[TBL] [Abstract][Full Text] [Related]
3. Profile of anticonvulsant action of levetiracetam, tiagabine and phenobarbital against seizures evoked by DMCM (methyl-6,7-dimethoxy-4-ethyl-β-carboline-3-carboxylate) in neonatal rats.
Kulick CV; Gutherz SB; Beck VC; Medvedeva N; Soper C; Forcelli PA
Eur J Pharmacol; 2014 Nov; 743():63-8. PubMed ID: 25246016
[TBL] [Abstract][Full Text] [Related]
4. Anticonvulsant effect of cannabinoid receptor agonists in models of seizures in developing rats.
Huizenga MN; Wicker E; Beck VC; Forcelli PA
Epilepsia; 2017 Sep; 58(9):1593-1602. PubMed ID: 28691158
[TBL] [Abstract][Full Text] [Related]
5. Azirino[1, 2-d][1, 4]benzodiazepine derivatives and related 1,4-benzodiazepines as anticonvulsant agents in DBA/2 mice.
De Sarro G; Chimirri A; Zappala M; Guisti P; Lipartiti M; De Sarro A
Gen Pharmacol; 1996 Oct; 27(7):1155-62. PubMed ID: 8981061
[TBL] [Abstract][Full Text] [Related]
6. Selective protection by adenosine receptor agonists against DMCM-induced seizures.
Petersen EN
Eur J Pharmacol; 1991 Mar; 195(2):261-5. PubMed ID: 1874275
[TBL] [Abstract][Full Text] [Related]
7. A systematic review and indirect treatment comparison of perampanel versus brivaracetam as adjunctive therapy in patients with focal-onset seizures with or without secondary generalization.
Trinka E; Tsong W; Toupin S; Patten A; Wilson K; Isojarvi J; James D
Epilepsy Res; 2020 Oct; 166():106403. PubMed ID: 32673969
[TBL] [Abstract][Full Text] [Related]
8. Evidence for a unique profile of levetiracetam in rodent models of seizures and epilepsy.
Klitgaard H; Matagne A; Gobert J; Wülfert E
Eur J Pharmacol; 1998 Jul; 353(2-3):191-206. PubMed ID: 9726649
[TBL] [Abstract][Full Text] [Related]
9. Behavioural and convulsant actions of two methyl esters of beta-carboline-3-carboxylic acid in photosensitive baboons and in DBA/2 mice.
Croucher M; De Sarro G; Jensen L; Meldrum B
Eur J Pharmacol; 1984 Sep; 104(1-2):55-60. PubMed ID: 6499918
[TBL] [Abstract][Full Text] [Related]
10. Anticonvulsant activity of azirino[1,2-d][1,4]benzodiazepines and related 1,4-benzodiazepines in mice.
De Sarro G; Chimirri A; McKernan R; Quirk K; Giusti P; De Sarro A
Pharmacol Biochem Behav; 1997 Sep; 58(1):281-9. PubMed ID: 9264104
[TBL] [Abstract][Full Text] [Related]
11. Perampanel exhibits anticonvulsant action against pentylentetrazol-induced seizures in immature rats.
Mareš P; Kubová H
Epilepsy Res; 2021 Jan; 169():106523. PubMed ID: 33296808
[TBL] [Abstract][Full Text] [Related]
12. Effects of two convulsant beta-carboline derivatives, DMCM and beta-CCM, on regional neurotransmitter amino acid levels and on in vitro D-[3H]aspartate release in rodents.
Chapman AG; Cheetham SC; Hart GP; Meldrum BS; Westerberg E
J Neurochem; 1985 Aug; 45(2):370-81. PubMed ID: 2861248
[TBL] [Abstract][Full Text] [Related]
13. Binding characteristics of brivaracetam, a selective, high affinity SV2A ligand in rat, mouse and human brain: relationship to anti-convulsant properties.
Gillard M; Fuks B; Leclercq K; Matagne A
Eur J Pharmacol; 2011 Aug; 664(1-3):36-44. PubMed ID: 21575627
[TBL] [Abstract][Full Text] [Related]
14. Hypersusceptibility to DMCM-induced seizures during diazepam withdrawal in mice: evidence for upregulation of NMDA receptors.
Tsuda M; Shimizu N; Yajima Y; Suzuki T; Misawa M
Naunyn Schmiedebergs Arch Pharmacol; 1998 Mar; 357(3):309-15. PubMed ID: 9550303
[TBL] [Abstract][Full Text] [Related]
15. Anti-convulsive and anti-epileptic properties of brivaracetam (ucb 34714), a high-affinity ligand for the synaptic vesicle protein, SV2A.
Matagne A; Margineanu DG; Kenda B; Michel P; Klitgaard H
Br J Pharmacol; 2008 Aug; 154(8):1662-71. PubMed ID: 18500360
[TBL] [Abstract][Full Text] [Related]
16. beta-Carboline gamma-aminobutyric acidA receptor inverse agonists modulate gamma-aminobutyric acid via the loreclezole binding site as well as the benzodiazepine site.
Stevenson A; Wingrove PB; Whiting PJ; Wafford KA
Mol Pharmacol; 1995 Dec; 48(6):965-9. PubMed ID: 8848011
[TBL] [Abstract][Full Text] [Related]
17. Investigating benzodiazepine receptor function in vivo using an intravenous infusion of DMCM.
Nutt DJ; Little HJ; Taylor SC; Minchin MC
Eur J Pharmacol; 1984 Aug; 103(3-4):359-62. PubMed ID: 6092108
[TBL] [Abstract][Full Text] [Related]
18. Perampanel, a potent AMPA receptor antagonist, protects against tetramethylenedisulfotetramine-induced seizures and lethality in mice: comparison with diazepam.
Zolkowska D; Dhir A; Rogawski MA
Arch Toxicol; 2021 Jul; 95(7):2459-2468. PubMed ID: 33914090
[TBL] [Abstract][Full Text] [Related]
19. Bidirectional effects of beta-carbolines in reflex epilepsy.
Chapman AG; De Sarro GB; Premachandra M; Meldrum BS
Brain Res Bull; 1987 Sep; 19(3):337-46. PubMed ID: 3119161
[TBL] [Abstract][Full Text] [Related]
20. Perampanel chronic treatment does not induce tolerance and decreases tolerance to clobazam in genetically epilepsy prone rats.
Citraro R; De Sarro C; Leo A; Donato di Paola E; Palma E; Russo E; De Sarro G
Epilepsy Res; 2018 Oct; 146():94-102. PubMed ID: 30092489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
